News from delmar pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 26, 2014, 08:00 ET

DelMar Pharmaceuticals Provides Update on VAL-083 Glioblastoma Clinical Trial

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update on the company's ongoing Phase I/II clinical trial for...

Dec 09, 2013, 08:00 ET

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), developer of advanced cancer therapeutics, today announced that their December 5th...

Dec 02, 2013, 16:11 ET

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com December 5th

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), developer of advanced cancer therapeutics, today announced that Jeffrey Bacha, B.Sc., MBA,...

Nov 22, 2013, 08:00 ET

DelMar Pharmaceuticals Presents Interim Phase 1/2 Clinical Data for VAL-083 in Glioblastoma at Society for Neuro-Oncology Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2...

Nov 14, 2013, 08:00 ET

DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced that the Company will present interim clinical...

Nov 11, 2013, 08:00 ET

DelMar Pharmaceuticals Gives Quarterly Shareholder Update

Dear Shareholders and Friends of DelMar Pharmaceuticals: I am pleased to provide you with an update as of the quarter ended September 30, 2013 and...

Oct 21, 2013, 08:00 ET

DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of data at the AACR-NCI-EORTC...

Oct 15, 2013, 08:00 ET

DelMar Pharmaceuticals to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" or "DelMar Pharma") today announced that the company would present an abstract entitled...

Oct 09, 2013, 08:00 ET

DelMar Pharma talks to Life Sciences IP Review (LSIPR) about creating new patents for shelved drugs to streamline path to patients

 The president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") Jeffrey Bacha spoke to Life Science IP...

Sep 19, 2013, 08:00 ET

DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") today announced a discussion on CEOLIVE.TV by Jeffrey Bacha,...

Sep 16, 2013, 12:09 ET

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), developer of advanced cancer therapeutics, today announced that their September 12th...

Sep 09, 2013, 08:00 ET

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com September 12th

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI), developer of advanced cancer therapeutics, today announced that Jeffrey Bacha, B.Sc., MBA,...

Sep 09, 2013, 08:00 ET

DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") and Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd., a subsidiary of Guagxi Wuzhou Zhongeng...

Sep 03, 2013, 08:00 ET

DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 15th...

Jun 10, 2013, 07:00 ET

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced that their June 6th RetailInvestorConferences.com presentation is now available for...

Jun 03, 2013, 08:00 ET

DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced that the company presented a poster entitled "Phase I/II Study of VAL-083...

May 31, 2013, 07:00 ET

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced that Jeffrey Bacha, B.Sc., MBA, President & CEO, will present at...

May 28, 2013, 08:00 ET

DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "Phase I/II Study of...

May 16, 2013, 08:37 ET

DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey...

Apr 10, 2013, 08:00 ET

DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of...